Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash Flows from Operating Activities:
Net loss	$ (449,566)	$ (1,331,341)
Adjustments to reconcile net loss to net cash used in operating activities -
Loss on Sale of Property and Equipment	34,707	0
Depreciation and amortization	7,165	21,231
Amortization of patents and trademarks	1,526	1,526
Stock based compensation	202,400	651,075
Deferred rent	(25,750)	0
Interest receivable	(5,043)	(4,988)
Accretion of debt discount	71,358	75,515
Change in fair value of warrants and embedded conversion option	(244,500)	0
Change in assets and liabilities -
Prepaid expenses and other current assets	(6,269)	(18,204)
Inventories	129,653	(64,309)
Other assets	32,375	0
Accounts payable, accrued expenses, accrued dividends, accrued compensation, accrued consulting and director fees, and other current liabilities	165,450	93,570
Net Cash Used in Operating Activities	(86,494)	(575,925)
Cash Flows from Investing Activities:
Patent costs	0	(7,400)
Net Cash Used in Investing Activities	0	(7,400)
Cash Flows from Financing Activities:
Proceeds from sale of common stock	30,000	100,000
Proceeds from exercise of warrants	0	42,922
Proceeds from convertible promissory note	126,000	100,000
Proceeds from officers and directors convertible loans	0	225,000
Repayment of notes payable	(141,323)	(1,497)
Net Cash Provided by Financing Activities	14,677	466,425
Net (decrease) increase in cash	(71,817)	(116,900)
Cash at beginning of year	118,228	166,758
Cash at end of year	46,411	49,858
Supplemental Disclosure of Cash Flow Information:
Cash paid during the year for interest	8,500	4,555
Non-Cash Investing and Financing Activities:
Common stock issued in satisfaction of liabilities	106,137	121,842
Reclassification of equity instrument to derivative liabilities	5,200	0
Debt discount for conversion and warrant rights	$ 0	$ 103,132